SCHEMBL10275655

SCHEMBL10275655

CCOC(=O)C(C=O)C(=O)OCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ALOX15 P16050 2/20 0.42
MGAM O43451 1/20 0.42
GAA P10253 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
SOAT1 P35610 1/20 0.42
HCAR2 Q8TDS4 1/20 0.39
TRPA1 O75762 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
GLO1 Q04760 1/20 0.38
MAPT P10636 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PIN1 Q13526 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6070239 0.88 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL15474317 0.86 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL27342284 0.79 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL241537 0.79 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL5689829 0.77 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL524836 0.77
SCHEMBL31324731 0.77
SCHEMBL3667483 0.75
SCHEMBL1495985 0.75 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL14881486 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112898152-B Preparation method of ethoxy diethyl methylene malonate 杭州新本立医药有限公司 2022-08-05 CN claimed
CN-113336754-B Fluorescent probe and preparation method thereof 天津全和诚科技有限责任公司 2022-05-17 CN claimed
CN-113336754-A Fluorescent probe and preparation method thereof 天津全和诚科技有限责任公司 2021-09-03 CN claimed
CN-112898152-A Preparation method of ethoxy diethyl methylene malonate 杭州新本立医药有限公司 2021-06-04 CN claimed
CN-113336754-B Fluorescent probe and preparation method thereof 天津全和诚科技有限责任公司 2022-05-17 CN disclosed
CN-113735728-A Preparation method of diethyl aminomalonate hydrochloride 苏州敬业医药化工有限公司 2021-12-03 CN disclosed
CN-113336754-A Fluorescent probe and preparation method thereof 天津全和诚科技有限责任公司 2021-09-03 CN disclosed
CN-105980345-B Method for continuously producing ketomalonic acid compound using flow reactor 组合化学工业株式会社 2019-12-20 CN disclosed
CN-110391037-A It is used to form the composition of electrode, using electrode and solar battery made of it 三星SDI株式会社 2019-10-29 CN disclosed
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US disclosed
CN-101061108-A Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives AVENTIS PHARMA SA (FR) 2007-10-24 CN disclosed
CN-1326852-C Benzofuran derivatives KOWA CO (JP) 2007-07-18 CN disclosed
CN-1759103-A Water-soluble phenylpyridazine derivative and medicine containing the same KOWA CO (JP) 2006-04-12 CN disclosed
CN-1756753-A Benzofuran derivatives KOWA CO (JP) 2006-04-05 CN disclosed
CN-1558903-A Water-soluble phenylpyridazine derivative and drug containing the same ������������ʽ���� 2004-12-29 CN disclosed
CN-87108295-A New alkane sulfonyl aniline derivative and its medicinal compositions and preparation method 1988-07-13 CN disclosed
CN-86102877-A The method for preparing bicyclic pyrazolidinones 1986-10-29 CN disclosed
EP-0020173-B1 IMIDAZOLE GUANIDINES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM MERCK & CO. INC. (US) 1983-02-09 EP disclosed
EP-0020173-A1 Imidazole guanidines, their preparation and compositions containing them MERCK & CO. INC. (US) 1980-12-10 EP disclosed
US-4220654-A Cyclic imidazole cyanoguanidines MERCK & CO., INC. (US) 1980-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 ALDH1A1 572/4885LMNA 1504/4885HSD17B10 1979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.